<DOC>
	<DOCNO>NCT01318837</DOCNO>
	<brief_summary>This study evaluate change active bladder symptom score ( OABSS ) , solifenacin treatment OAB subject .</brief_summary>
	<brief_title>A Study Evaluate Response Over Active Bladder Symptom Score Solifenacin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Symptoms OAB 3 month longer At least 1 urgency episode last 3 day Symptoms OAB verify screen 3day bladder diary , define : . Number micturition ≥8 times/day b . Number urgency episode 3 day ≥3 Significant stress incontinence mixed stress/urge incontinence Subject indwell catheter practice intermittent selfcatheterization Symptomatic urinary tract infection , chronic inflammation Diabetic neuropathy Subjects prohibit take solifenacin contraindication Drug nondrug treatment OAB start , quit change 4 week Participation clinical trial 30 day except Part1 RESORT Diabetic neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>OABSS</keyword>
	<keyword>IPSS</keyword>
	<keyword>PPBC</keyword>
	<keyword>Solifenacin</keyword>
</DOC>